COFCO Biotechnology Hits Day Low of CNY 6.75 Amid Price Pressure

COFCO Biotechnology Co., Ltd., a prominent player in the specialty chemicals sector, experienced a notable decline of 3.94% on March 5, 2026. The stock reached an intraday low of CNY 6.75, reflecting a challenging trading day amid broader market movements. In terms of performance metrics, COFCO Biotechnology has shown a mixed trajectory over various time frames. While the stock has gained 6.56% over the past month and 22.66% over the past year, it has faced significant hurdles in the longer term, with a decline of 24.22% over the past three years and 29.84% over the past five years. The company's financial health is characterized by a debt-to-equity ratio of 0.14, indicating a relatively low level of debt. However, its return on equity stands at 0.69%, suggesting modest profitability. Despite these challenges, COFCO Biotechnology has reported positive results for the last four consecutive quarters, with a notable increase in net profit and operating cash flow. As the company navigates its current market position, these financial indicators will be crucial for understanding its ongoing performance.